| Health / Medical Topics |
Premarket Review
The examination of data and information in an application for premarket review described in sections 505, 510(k), 513(f), 515, or 520(g) or 520(l) of the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act of data and information contained in any investigational new drug application, investigational device exemption, new drug application, biologics license application, device premarket notification, device reclassification petition, and premarket approval application. (NCI Thesaurus)
YOU MAY ALSO LIKE
A premarket submission made to FDA to demonstrate that a device to be marketed is at least as safe and effective as…
A premarket submission made to FDA to review and evaluate the safety and effectiveness of a Class III medical device.
Stability data submitted for a PMA application.
A hematologic disorder which does not display the morphologic and/or clinical characteristics of an overt malignancy. Representative examples include atypical lymphoproliferative…
Cells which show sign/s, that they can become cancerous.
A term used to describe a condition that may (or is likely to) become cancer. Also called precancerous.
